Jeremy Grantham's GMAB Position Overview
Jeremy Grantham (via Grantham, Mayo, Van Otterloo & Co. LLC) currently holds 7,563 shares of Genmab A/S (GMAB) worth $269,810, representing 0.00% of the portfolio. First purchased in 2026-Q3, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Jeremy Grantham has initiated a new position in GMAB, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Jeremy Grantham's Genmab A/S (GMAB) Holding Value Over Time
Track share changes against reported price movement
Quarterly Genmab A/S (GMAB) Trades by Jeremy Grantham
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2026 | +7,563 | New Buy | 7,563 | $35.67 |
Jeremy Grantham's Genmab A/S Investment FAQs
Jeremy Grantham first purchased Genmab A/S (GMAB) in Q3 2026, acquiring 7,563 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jeremy Grantham has held Genmab A/S (GMAB) for 1 quarters since Q3 2026.
Jeremy Grantham's largest addition to Genmab A/S (GMAB) was in Q3 2026, adding 7,563 shares worth $269,810.
According to the latest 13F filing for Q3 2026, Jeremy Grantham's firm, Grantham, Mayo, Van Otterloo & Co. LLC, owns 7,563 shares of Genmab A/S (GMAB), valued at approximately $269,810.
As of the Q3 2026 filing, Genmab A/S (GMAB) represents approximately 0.00% of Jeremy Grantham's publicly disclosed stock portfolio, making it one of their key holdings.
Jeremy Grantham's peak holding in Genmab A/S (GMAB) was 7,563 shares, as reported at the end of Q3 2026.